Healthcare -
Biotechnology - NASDAQ - US
$ 0.2962
-0.135 %
$ 21.5 M
Market Cap
-0.4
P/E
INAB - LONG-TERM DEBT
Long-term Debt INAB - IN8bio, Inc.
3.38 M
LAST VALUE
37.62%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR